| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| REGNRegeneron Pharmaceuticals, Inc. | 107.56B | 781.67 | 18.84 | 0.99% | 31.41% | 14.41% | 3.79% | 0.09 |
| CTMXCytomX Therapeutics, Inc. | 430.14M | 5.37 | 14.13 | 36.45% | 24.66% | 26.09% | ||
| PRTCPureTech Health plc | 405.3M | 16.77 | 8.39 | 44.98% | -495.91% | -8.53% | 0.05 | |
| DNAGinkgo Bioworks Holdings, Inc. | 327.53M | 6.75 | -1.20 | -25.06% | -183.81% | -61.5% | 0.82 | |
| BCYCBicycle Therapeutics plc | 111.38M | 5.73 | -1.98 | 30.76% | -8.85% | -40.53% | 0.01 | |
| CCCCC4 Therapeutics, Inc. | 261.67M | 2.70 | -2.13 | -100% | -40.92% | 0.23 | ||
| MOLNMolecular Partners AG | 187.84M | 5.02 | -2.43 | -29.38% | -10.87% | -63.06% | 0.02 | |
| RXRXRecursion Pharmaceuticals, Inc. | 1.94B | 3.67 | -2.55 | 26.92% | -8.65% | -57.01% | 0.07 |
Analyze head-to-head performance against top industry competitors across valuation, growth, and profitability metrics.
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 19.36M | 21.38M | 33.2M | 45.78M | 31.1M | 20.76M | 35.58M | 0 |
| Revenue Growth % | - | 10.42% | 55.25% | 37.93% | -32.08% | -33.25% | 71.44% | -100% |
| Cost of Goods Sold | 28.59M | 0 | 78.44M | 0 | 0 | 7.74M | 0 | 0 |
| COGS % of Revenue | 147.66% | - | 236.3% | - | - | 37.28% | - | - |
| Gross Profit | -9.23M | 21.38M | -45.24M | 45.78M | 31.1M | 13.02M | 35.58M | 0 |
| Gross Margin % | -47.66% | 100% | -136.3% | 100% | 100% | 62.72% | 100% | - |
| Gross Profit Growth % | - | 331.7% | -311.61% | 201.19% | -32.08% | -58.13% | 173.32% | -100% |
| Operating Expenses | 35.75M | 56.83M | 15.2M | 127.92M | 160.63M | 152.05M | 155.2M | 151.17M |
| OpEx % of Revenue | 184.64% | 265.81% | 45.8% | 279.39% | 516.56% | 732.56% | 436.15% | - |
| Selling, General & Admin | 7.16M | 8.77M | 15.2M | 33.25M | 42.79M | 42.08M | 42.12M | 36.2M |
| SG&A % of Revenue | 36.98% | 41.04% | 45.8% | 72.63% | 137.6% | 202.74% | 118.38% | - |
| Research & Development | 28.59M | 48.06M | 78.44M | 94.67M | 117.84M | 117.71M | 110.64M | 104.24M |
| R&D % of Revenue | 147.66% | 224.77% | 236.3% | 206.76% | 378.96% | 567.09% | 310.92% | - |
| Other Operating Expenses | -7K | 0 | -78.44M | 0 | 0 | -7.74M | 2.44M | 10.73M |
| Operating Income | -16.39M | -35.45M | -60.45M | -82.13M | -129.53M | -139.03M | -119.61M | -115.22M |
| Operating Margin % | -84.64% | -165.81% | -182.1% | -179.39% | -416.56% | -669.84% | -336.15% | - |
| Operating Income Growth % | - | -116.32% | -70.51% | -35.87% | -57.71% | -7.33% | 13.97% | 3.67% |
| EBITDA | -12.82M | -33.86M | -58.83M | -80.64M | -127.86M | -131.29M | -117.8M | -115.22M |
| EBITDA Margin % | -66.18% | -158.35% | -177.23% | -176.13% | -411.17% | -632.56% | -331.04% | - |
| EBITDA Growth % | - | -164.18% | -73.77% | -37.07% | -58.55% | -2.69% | 10.28% | 2.19% |
| D&A (Non-Cash Add-back) | 3.57M | 1.59M | 1.62M | 1.49M | 1.68M | 7.74M | 1.82M | 0 |
| EBIT | -16.39M | -33.3M | -60.45M | -81.75M | -125.96M | -129.84M | -105.19M | 0 |
| Net Interest Income | 685K | 1.83M | -836K | -1.76M | 1.36M | 8.44M | 14.43M | 0 |
| Interest Income | 685K | 1.83M | 393K | 387K | 3.58M | 9.81M | 14.43M | 0 |
| Interest Expense | 0 | 0 | 1.23M | 2.15M | 2.22M | 1.37M | 0 | 0 |
| Other Income/Expense | 678K | 2.16M | -5.26M | -1.76M | 1.36M | 7.82M | 14.43M | 10.35M |
| Pretax Income | -15.71M | -33.3M | -65.71M | -83.89M | -128.18M | -131.21M | -105.19M | -104.87M |
| Pretax Margin % | -81.14% | -155.72% | -197.95% | -183.23% | -412.19% | -632.17% | -295.6% | - |
| Income Tax | 0 | 804K | 626K | 0 | 0 | 1.28M | 131K | -121K |
| Effective Tax Rate % | 100% | 102.41% | 100.95% | 100% | 100% | 100.98% | 100.12% | 100.12% |
| Net Income | -15.71M | -34.1M | -66.33M | -83.89M | -128.18M | -132.49M | -105.32M | -104.99M |
| Net Margin % | -81.14% | -159.48% | -199.83% | -183.23% | -412.19% | -638.34% | -295.96% | - |
| Net Income Growth % | - | -117.04% | -94.54% | -26.47% | -52.79% | -3.37% | 20.51% | 0.31% |
| Net Income (Continuing) | -15.71M | -34.1M | -66.33M | -83.89M | -128.18M | -132.49M | -105.32M | -104.99M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.06 | -0.79 | -1.54 | -1.82 | -2.62 | -2.67 | -1.52 | -1.27 |
| EPS Growth % | - | 25.47% | -94.94% | -18.18% | -43.96% | -1.91% | 43.07% | 16.45% |
| EPS (Basic) | -1.06 | -0.79 | -1.54 | -1.82 | -2.62 | -2.67 | -1.52 | -1.27 |
| Diluted Shares Outstanding | 42.09M | 42.99M | 43.06M | 46.04M | 48.86M | 49.64M | 69.37M | 82.89M |
| Basic Shares Outstanding | 14.79M | 42.99M | 43.06M | 46.04M | 48.86M | 49.64M | 69.37M | 82.89M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - |
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 123.53M | 96.77M | 381.01M | 325.69M | 287.56M | 271.19M | 257.77M | 258.11M |
| Cash & Short-Term Investments | 36.31M | 90.55M | 371.69M | 309.28M | 276.15M | 253.68M | 244.9M | 248.54M |
| Cash Only | 36.31M | 90.55M | 181.73M | 76.12M | 29.75M | 126.59M | 55.5M | 74.6M |
| Short-Term Investments | 0 | 0 | 189.96M | 233.16M | 246.4M | 127.09M | 189.41M | 173.93M |
| Accounts Receivable | 86.44M | 4.62M | 4.48M | 5.72M | 1.47M | 11.8M | 3.1M | 2.4M |
| Days Sales Outstanding | 1.63K | 78.92 | 49.3 | 45.57 | 17.29 | 207.49 | 31.82 | - |
| Inventory | 0 | 0 | 0 | 0 | -60.96M | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 0 | 0 | 0 | 70.89M | 5.71M | 9.76M | 7.17M |
| Total Non-Current Assets | 22.96M | 21.49M | 19.13M | 181.08M | 143.28M | 105.26M | 91.83M | 100.97M |
| Property, Plant & Equipment | 20.38M | 18.92M | 16.55M | 35.05M | 77.52M | 71.09M | 63.38M | 45.28M |
| Fixed Asset Turnover | 0.95x | 1.13x | 2.01x | 1.31x | 0.40x | 0.29x | 0.56x | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 2.58M | 0 | 0 | 142.2M | 60.96M | 28.01M | 22.36M | 0 |
| Other Non-Current Assets | 0 | 2.58M | 2.58M | 3.82M | 4.8M | 6.17M | 6.1M | 55.69M |
| Total Assets | 146.49M | 118.26M | 400.14M | 506.76M | 430.84M | 376.45M | 349.6M | 359.07M |
| Asset Turnover | 0.13x | 0.18x | 0.08x | 0.09x | 0.07x | 0.06x | 0.10x | - |
| Asset Growth % | - | -19.27% | 238.35% | 26.65% | -14.98% | -12.62% | -7.13% | 2.71% |
| Total Current Liabilities | 23.95M | 33.64M | 43.85M | 51.25M | 44.55M | 42.77M | 45.18M | 33.03M |
| Accounts Payable | 1.15M | 5.38M | 5.68M | 4.51M | 1.17M | 1.45M | 1.33M | 858K |
| Days Payables Outstanding | 14.73 | - | 26.44 | - | - | 68.22 | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 2.29M | 0 | 0 | 6.37M |
| Deferred Revenue (Current) | 19.11M | 20.7M | 27.6M | 31.8M | 16.62M | 15.47M | 18.71M | 12.49M |
| Other Current Liabilities | 1.26M | 3.33M | 4.19M | 5.5M | 3.11M | 9.39M | 9.3M | 14.17M |
| Current Ratio | 5.16x | 2.88x | 8.69x | 6.36x | 6.46x | 6.34x | 5.71x | 7.81x |
| Quick Ratio | 5.16x | 2.88x | 8.69x | 6.36x | 7.82x | 6.34x | 5.71x | 7.81x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 202.29M | 196.58M | 75.5M | 65.91M | 97.06M | 87.57M | 88.44M | 69.46M |
| Long-Term Debt | 0 | 0 | 10.05M | 10.77M | 9.2M | 0 | 0 | 53.62M |
| Capital Lease Obligations | 13.75M | 12.87M | 11.83M | 30.78M | 70.97M | 65.76M | 59.98M | 0 |
| Deferred Tax Liabilities | -13.75M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 111M | 111M | 0 | 0 | 0 | 0 | 0 | 15.84M |
| Total Liabilities | 226.24M | 230.22M | 119.35M | 117.16M | 141.61M | 130.34M | 133.62M | 102.49M |
| Total Debt | 14.48M | 13.75M | 22.92M | 42.88M | 87.15M | 70.98M | 65.76M | 59.98M |
| Net Debt | -21.83M | -76.8M | -158.81M | -33.24M | 57.4M | -55.61M | 10.26M | -14.62M |
| Debt / Equity | - | - | 0.08x | 0.11x | 0.30x | 0.29x | 0.30x | 0.23x |
| Debt / EBITDA | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | -49.19x | -38.29x | -58.45x | -101.26x | - | - |
| Total Equity | -79.75M | -111.96M | 280.79M | 389.61M | 289.23M | 246.11M | 215.99M | 256.59M |
| Equity Growth % | - | -40.39% | 350.79% | 38.75% | -25.76% | -14.91% | -12.24% | 18.8% |
| Book Value per Share | -1.89 | -2.60 | 6.52 | 8.46 | 5.92 | 4.96 | 3.11 | 3.10 |
| Total Shareholders' Equity | -79.75M | -111.96M | 280.79M | 389.61M | 289.23M | 246.11M | 215.99M | 256.59M |
| Common Stock | 1K | 0 | 4K | 5K | 5K | 6K | 7K | 9K |
| Retained Earnings | -83.39M | -117.49M | -183.82M | -267.71M | -395.89M | -528.38M | -633.7M | -738.69M |
| Treasury Stock | -6.14M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -2.5M | 0 | 13K | -775K | -4.14M | -127K | 53K | 50K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -16.98M | 55.61M | -67.25M | -86.97M | -105.94M | -106.84M | -65.16M | -98.69M |
| Operating CF Margin % | -87.69% | 260.11% | -202.59% | -189.94% | -340.68% | -514.73% | -183.11% | - |
| Operating CF Growth % | - | 427.51% | -220.92% | -29.32% | -21.82% | -0.85% | 39.01% | -51.47% |
| Net Income | -15.71M | -34.1M | -66.33M | -83.89M | -128.18M | -132.49M | -105.32M | -104.99M |
| Depreciation & Amortization | 1.27M | 1.59M | 1.62M | 1.49M | 1.68M | 1.88M | 1.82M | 1.96M |
| Stock-Based Compensation | 582K | 1.64M | 3.43M | 21.51M | 30.02M | 27.23M | 29.66M | 19.1M |
| Deferred Taxes | 66K | 350K | 5.58M | 1.88M | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 2.37M | 1.14M | 1.63M | 2.13M | 7.32M | 3.48M | 1.03M | -14.76M |
| Working Capital Changes | -5.56M | 84.98M | -13.18M | -30.09M | -16.78M | -6.94M | 7.65M | 0 |
| Change in Receivables | -84.94M | 81.81M | 139K | -1.23M | 4.24M | -10.33M | 8.7M | 701K |
| Change in Inventory | -2.22M | 2.17M | -1.58M | -2.63M | 0 | 0 | 0 | 0 |
| Change in Payables | 578K | 4.23M | 467K | -1.18M | -3.33M | 273K | -119K | -468K |
| Cash from Investing | 36.92M | -1.62M | -190.5M | -189.34M | 58.42M | 158.35M | -51.27M | -8.6M |
| Capital Expenditures | -2.69M | -1.35M | -650K | -1.28M | -5.5M | -1.71M | -180K | -607K |
| CapEx % of Revenue | 13.89% | 6.31% | 1.96% | 2.79% | 17.67% | 8.23% | 0.51% | - |
| Acquisitions | 0 | 63K | 189.85M | 188.06M | -63.92M | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - |
| Other Investing | 39.61M | 0 | -189.85M | -188.06M | 63.92M | 0 | 0 | 0 |
| Cash from Financing | 1.96M | 244K | 348.93M | 171.4M | 1.15M | 45.49M | 45.34M | 126.4M |
| Debt Issued (Net) | 0 | 0 | 11.97M | 0 | 0 | -12.5M | 0 | 0 |
| Equity Issued (Net) | 1000K | -30K | 1000K | 1000K | 777K | 1000K | 1000K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -63K | -30K | -194K | 0 | 0 | -110K | -194K | -193K |
| Other Financing | -63K | 274K | -3.45M | 1.94M | 370K | 426K | 1.16M | 126.4M |
| Net Change in Cash | 21.9M | 54.24M | 91.18M | -104.9M | -46.37M | 97M | -71.09M | 19.1M |
| Free Cash Flow | -19.67M | 54.27M | -67.9M | -88.24M | -111.44M | -108.55M | -65.34M | -99.3M |
| FCF Margin % | -101.58% | 253.8% | -204.55% | -192.73% | -358.36% | -522.96% | -183.61% | - |
| FCF Growth % | - | 375.88% | -225.12% | -29.96% | -26.28% | 2.59% | 39.81% | -51.98% |
| FCF per Share | -0.47 | 1.26 | -1.58 | -1.92 | -2.28 | -2.19 | -0.94 | -1.20 |
| FCF Conversion (FCF/Net Income) | 1.08x | -1.63x | 1.01x | 1.04x | 0.83x | 0.81x | 0.62x | 0.94x |
| Interest Paid | 0 | 0 | 820K | 0 | 0 | 990K | 0 | 0 |
| Taxes Paid | 0 | 1.09M | 143K | 0 | 0 | 1M | 0 | 0 |
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | -78.58% | -25.03% | -37.76% | -49.5% | -45.58% | -44.44% |
| Return on Invested Capital (ROIC) | - | - | -37.17% | -25.76% | -27.64% | -38.83% | -43.05% | -36.91% |
| Gross Margin | -47.66% | 100% | -136.3% | 100% | 100% | 62.72% | 100% | - |
| Net Margin | -81.14% | -159.48% | -199.83% | -183.23% | -412.19% | -638.34% | -295.96% | - |
| Debt / Equity | - | - | 0.08x | 0.11x | 0.30x | 0.29x | 0.30x | 0.23x |
| Interest Coverage | - | - | -49.19x | -38.29x | -58.45x | -101.26x | - | - |
| FCF Conversion | 1.08x | -1.63x | 1.01x | 1.04x | 0.83x | 0.81x | 0.62x | 0.94x |
| Revenue Growth | - | 10.42% | 55.25% | 37.93% | -32.08% | -33.25% | 71.44% | -100% |
Explore detailed financial history, valuation models, and returns analysis
DCF models, peer multiples & analyst estimates
Historical returns with dividends reinvested
Yield, growth, payout safety & DRIP calculator
EPS trends, net income & profitability analysis
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of valuation, profitability & efficiency metrics